Bollard Group LLC - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 152 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bollard Group LLC ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$27,000
-6.9%
3830.0%0.00%0.0%
Q4 2021$29,000
+31.8%
3830.0%0.00%0.0%
Q3 2021$22,000
+29.4%
3830.0%0.00%0.0%
Q2 2021$17,000
-10.5%
3830.0%0.00%0.0%
Q1 2021$19,000
+18.8%
3830.0%0.00%0.0%
Q4 2020$16,000
-11.1%
3830.0%0.00%0.0%
Q3 2020$18,000
-77.5%
383
-75.9%
0.00%
-66.7%
Q2 2020$80,0001,5910.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 1,546,097$66,590,0009.91%
RA Capital Management 1,539,586$66,310,0006.70%
SENZAR ASSET MANAGEMENT, LLC 255,128$10,988,0004.20%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 158,315$6,819,0001.56%
Sarissa Capital Management LP 105,000$4,522,0001.54%
Ghost Tree Capital, LLC 50,000$2,154,0001.52%
BENNETT LAWRENCE MANAGEMENT L L C/NY 118,445$5,102,0000.90%
WALL STREET ASSOCIATES 219,200$9,441,0000.81%
Granite Point Capital Management, L.P. 25,000$1,077,0000.74%
BAILARD, INC. 91,500$3,941,0000.61%
View complete list of ENANTA PHARMACEUTICALS INC shareholders